Improved techniques in identifying the chromosome changes and the affected
genes that are involved in acute leukemias have led to improved treatments
for these diseases. Identification of consistent chromosomal changes has al
lowed us to target the location of particular genes and has enabled us to f
ocus our treatments more specifically to certain subtypes of leukemia. Tran
slocations, in particular, are common cytogenetic abnormalities in human le
ukemia, and the prevalence of certain types of translocations varies with a
ge. Cancers, lymphomas and leukemias are now known to be genetic diseases a
nd it is recognized that genotype-specific therapies should be used that ta
ke into account the genetic alterations of the particular leukemia.